Medicare Enrolled

Dr. Diego Rubinowicz, M.D.

Urology Physician · Loxahatchee, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
13005 SOUTHERN BLVD STE 135, Loxahatchee, FL 33470
5616151234
In practice since 2006 (19 years)
NPI: 1669483145 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rubinowicz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubinowicz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rubinowicz

Dr. Diego Rubinowicz is an urology physician in Loxahatchee, FL, with 19 years in practice. Based on federal Medicare data, Dr. Rubinowicz performed 2,847 Medicare services across 1,670 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rubinowicz received a total of $5,248 from 43 pharmaceutical and/or device companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rubinowicz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 36% volume in FL$ $5,248 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,847
Medicare services
Top 36% in FL for urology physician
1,670
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~150 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)656$100$221
Automated urinalysis559$2$20
Creatinine test (kidney function)559$5$20
Unclassified drugs318$90$209
Office visit, established patient (20-29 min)218$72$150
New patient office visit (45-59 min)121$129$344
Bladder ultrasound after voiding110$8$42
Diagnostic exam of bladder and urethra using an endoscope58$193$443
Office visit, established patient (10-19 min)56$45$91
Ultrasound scan of pelvic region through rectum39$109$294
Placement of hormone pellet under skin28$45$228
Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less24$79$203
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings18$28$427
Electronic assessment of bladder emptying17$6$54
Complex measurement of pressure of urine flow in bladder with voiding pressure studies16$288$666
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle16$27$71
Biopsy of prostate gland12$198$480
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope11$595$1,824
Ultrasonic guidance for needle placement11$47$436
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,248
Total received (2018-2024)
Avg $750/year across 7 years
Top 40% in FL for urology physician
43
Companies
171
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,083 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$164 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$984
2023
$1,179
2022
$1,135
2021
$650
2020
$182
2019
$331
2018
$787

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$549
PROCEPT BioRobotics Corporation
$445
Antares Pharma, Inc.
$376
Endo Pharmaceuticals Inc.
$360
Olympus America Inc.
$313
Janssen Biotech, Inc.
$303
Boston Scientific Corporation
$270
PFIZER INC.
$237
Myovant Sciences Inc.
$193
Laborie Medical Technologies Corp.
$186
C. R. Bard, Inc. & Subsidiaries
$172
Myriad Genetic Laboratories, Inc.
$154
EDAP TECHNOMED INC
$149
Sumitomo Pharma America, Inc.
$131
Tolmar, Inc.
$118
NeoTract Inc.
$117
Janssen Scientific Affairs, LLC
$113
BOSTON SCIENTIFIC CORPORATION
$108
Becton, Dickinson and Company
$97
Janssen Products, LP
$85
Medtronic, Inc.
$65
Blue Earth Diagnostics Limited
$62
Supernus Pharmaceuticals, Inc.
$60
ABBVIE INC.
$50
AbbVie Inc.
$49
Allergan, Inc.
$45
ROCHESTER MEDICAL CORPORATION
$44
Endo USA, Inc.
$41
Accord Healthcare, Inc.
$40
Kowa Pharmaceuticals America, Inc.
$37
AbbVie, Inc.
$36
Coloplast Corp
$31
Bayer HealthCare Pharmaceuticals Inc.
$26
UROVANT SCIENCES INC
$23
Ferring Pharmaceuticals Inc.
$22
Novartis Pharmaceuticals Corporation
$22
MEDIVATION FIELD SOLUTIONS LLC
$20
ACCORD HEALTHCARE, INC.
$20
Provepharm Inc.
$18
Avadel Specialty Pharmaceuticals, LLC
$16
Profound Medical Corp.
$15
Photocure Inc
$15
Dendreon Pharmaceuticals LLC
$14
Top 3 companies account for 26.1% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BLUDIGO · BOTOX · Bard InLay Optima Ureteral Stent with HydroGlide Guidewire · Bard Urinary Drainage Bag · CAMCEVI · CYSVIEW · EDEX · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL - BPH · GENERAL KIDNEY STONE DISEASE · INTERSTIM · LITHOVUE · LOCAMETZ · LUPRON DEPOT · NOCDURNA · Noctiva · Nubeqa · OES CYSTONEPHROFIBERSCOPE · ORGOVYX · OTREXUP · Olympus Resection Disposables · Optilume BPH Drug Coated Balloon Catheter · Otrexup · POSLUMA · PROLARIS · PROVENGE · REZUM · SEGLENTIS · SOLTIVE · SPACEOAR VUE · SpaceOAR VUE System - 10mL · SpeediCath · TESTOPEL · TLANDO · TOVIAZ · Torosa · Tulsa-Pro · UGN Laser Capital · UroLift · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $184 per 100 Medicare services performed
Looking for a urology physician in Loxahatchee?
Compare urology physicians in the Loxahatchee area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
46
Per 100K population
3.1
County median income
$81,115
Nearest hospital
HCA FLORIDA PALMS WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rubinowicz is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rubinowicz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rubinowicz performed 656 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubinowicz receive payments from pharmaceutical companies?
Yes. Dr. Rubinowicz received a total of $5,248 from 43 companies across 171 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubinowicz's costs compare to other urology physicians in Loxahatchee?
Dr. Rubinowicz's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubinowicz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →